https://ergomedcro.com/news-events/ 2026-08-20T11:57:24+00:00 https://ergomedcro.com/124878-2/ 2024-08-23T16:38:51+00:00 https://ergomedcro.com/wp-content/uploads/2024/08/Cambridge-Header-Banner.png https://ergomedcro.com/press-release-ergomed-announces-launch-of-its-rare-disease-innovation-center/ 2024-08-23T17:11:51+00:00 https://ergomedcro.com/wp-content/uploads/2024/08/RDIC-image-news.png https://ergomedcro.com/press-release-ergomed-acquires-adamas-consulting-group-limited/ 2024-08-23T17:20:40+00:00 https://ergomedcro.com/dr-marie-edith-bonneterre-appointed-as-ergomed-vice-president-head-of-global-medical-affairs/ 2024-08-23T17:44:19+00:00 https://ergomedcro.com/maximizing-the-potential-of-site-centric-services-2/ 2024-11-07T20:43:52+00:00 https://ergomedcro.com/leading-the-way-in-oncology-clinical-research/ 2024-11-07T20:44:02+00:00 https://ergomedcro.com/leading-the-way-in-rare-disease-clinical-research/ 2024-11-07T20:44:10+00:00 https://ergomedcro.com/discover-our-oncology-advantage/ 2024-11-07T20:50:18+00:00 https://ergomedcro.com/discover-our-rare-disease-advantage-fact-sheet/ 2024-11-07T20:54:44+00:00 https://ergomedcro.com/site-advantage/ 2024-11-07T20:58:59+00:00 https://ergomedcro.com/rare-disease-site-advantage/ 2024-11-07T21:03:21+00:00 https://ergomedcro.com/datasheet-ergomeds-advanced-therapy-clinical-trial-experience/ 2024-11-07T21:12:41+00:00 https://ergomedcro.com/datasheet-ergomeds-real-world-evidence-rwe-experience/ 2024-11-07T21:19:31+00:00 https://ergomedcro.com/white-paper-identifying-challenges-in-rare-cancers/ 2024-11-11T00:46:34+00:00 https://ergomedcro.com/wp-content/uploads/2024/08/White-Paper-Hero.png https://ergomedcro.com/perspectives-on-patient-focused-drug-development-in-rare-disease/ 2024-11-11T01:51:06+00:00 https://ergomedcro.com/wp-content/uploads/2024/08/rare_disease_1920x960px.jpg https://ergomedcro.com/from-technology-to-ai-navigating-the-path-towards-decentralized-trials-in-oncology/ 2024-11-11T01:52:40+00:00 https://ergomedcro.com/webinar-implementation-of-compassionate-use-programs-in-heterogeneous-regulatory-environments/ 2024-11-11T01:54:04+00:00 https://ergomedcro.com/rare-cancers-recommendations-for-oncology-clinical-development/ 2024-11-22T17:10:02+00:00 https://ergomedcro.com/innovative-approaches-in-oncology-clinical-trials/ 2024-12-04T11:16:27+00:00 https://ergomedcro.com/the-future-of-oncology-research-trends-and-predictions-from-a-leading-oncology-cro/ 2024-12-04T11:16:50+00:00 https://ergomedcro.com/5-things-you-need-to-know-about-picking-the-right-cro-for-rare-disease-programs/ 2024-12-04T11:17:17+00:00 https://ergomedcro.com/effective-engagement-strategies-with-patient-advocacy-organizations-for-drug-development-companies/ 2024-12-17T14:12:15+00:00 https://ergomedcro.com/key-strategies-for-clinical-development-in-rare-cancers/ 2024-12-19T14:40:26+00:00 https://ergomedcro.com/6-actionable-strategies-to-engage-rare-disease-patient-advocacy-organizations-effectively/ 2025-01-10T14:24:24+00:00 https://ergomedcro.com/tips-and-tricks-for-developing-rare-cancer-clinical-trials-from-leading-oncology-cro/ 2025-01-16T20:29:49+00:00 https://ergomedcro.com/ergomed-plc-outsourcing-clinical-trials-west-coast/ 2025-01-24T10:21:40+00:00 https://ergomedcro.com/wp-content/uploads/2015/09/OCT-West-Coast-2024-booth-event-website.png https://ergomedcro.com/wp-content/uploads/2024/11/Julia-Day-1-modified.png https://ergomedcro.com/wp-content/uploads/2024/11/Chris-Henne-modified.png https://ergomedcro.com/beyond-data-privacy-compliance-protecting-patients-empowering-progress/ 2025-01-28T00:15:34+00:00 https://ergomedcro.com/rare-disease-day-2025-an-artists-journey-with-spinal-muscular-atrophy/ 2025-02-27T00:01:48+00:00 https://ergomedcro.com/the-new-era-of-medical-monitoring/ 2025-03-16T22:06:39+00:00 https://ergomedcro.com/ergomed-contributes-to-landmark-head-and-neck-cancer-study/ 2025-03-28T11:59:35+00:00 https://ergomedcro.com/wp-content/uploads/2025/03/Ergomed-Contributes-to-Landmark-Head-and-Neck-Cancer-Study.jpg https://ergomedcro.com/accelerating-early-phase-oncology-study-development/ 2025-04-24T14:39:12+00:00 https://ergomedcro.com/choosing-the-cro-for-rare-disease-research/ 2025-04-25T00:58:03+00:00 https://ergomedcro.com/addressing-the-complexities-of-rare-disease-trials/ 2025-04-25T00:59:39+00:00 https://ergomedcro.com/navigating-the-complex-world-of-first-in-human-oncology-trials/ 2025-05-05T03:18:11+00:00 https://ergomedcro.com/exploring-the-challenges-of-designing-and-executing-first-in-human-oncology-trials-internal/ 2025-05-07T12:04:24+00:00 https://ergomedcro.com/wp-content/uploads/2024/09/OCT24-Patient-Advocacy-webinar-registration-page.jpg https://ergomedcro.com/building-bridges-to-success-the-essential-role-of-vendor-managers-in-clinical-research-pharmacovigilance/ 2025-05-14T11:46:35+00:00 https://ergomedcro.com/wp-content/uploads/2024/08/Aug23-Vendor-Management-webinar-sliding-banner.png https://ergomedcro.com/us-ssu-team-named-finalists-for-pharmatimes-clinical-researcher-of-the-year-the-americas-2024/ 2025-05-14T11:48:59+00:00 https://ergomedcro.com/wp-content/uploads/2024/10/PharmaTimes-Start-Up-Team-Category-scaled.jpg https://ergomedcro.com/press-release-ergomed-expands-u-s-presence-with-new-office-in-boston/ 2025-05-14T11:49:22+00:00 https://ergomedcro.com/press-release-ergomed-expands-presence-in-india-with-new-office-in-pune/ 2025-05-14T11:49:38+00:00 https://ergomedcro.com/wp-content/uploads/2024/08/PR-Pune-office-opening-1.png https://ergomedcro.com/strategic-considerations-and-innovations-that-successfully-impact-rare-disease-drug-development/ 2025-05-14T11:51:18+00:00 https://ergomedcro.com/ergomed-ssu-team-finalists-in-the-pharmatimes-international-clinical-researcher-of-the-year-2025/ 2025-05-14T11:53:55+00:00 https://ergomedcro.com/wp-content/uploads/2025/03/Start-Up-Team-Category-1200-x-1600-px-2.jpg https://ergomedcro.com/cel-sci-selects-ergomed-as-cro-as-it-gears-up-for-confirmatory-fda-registration-study-of-multikine-in-head-and-neck-cancer/ 2025-05-14T11:54:31+00:00 https://ergomedcro.com/wp-content/uploads/2024/10/Cel-Sci-partnership-scaled.jpg https://ergomedcro.com/early-involvement-of-patients-in-pharmaceutical-research-and-development-for-rare-diseases/ 2025-05-14T11:54:49+00:00 https://ergomedcro.com/early-strategic-consulting-for-clinical-development-reducing-risk-accelerating-progress/ 2025-05-19T09:53:15+00:00 https://ergomedcro.com/maximizing-impact-in-rare-and-oncology-trials-through-advocacy-and-kol-collaboration/ 2025-05-21T13:35:57+00:00 https://ergomedcro.com/empowering-sites-engaging-patients-the-future-of-clinical-trial-delivery/ 2025-05-22T11:49:10+00:00 https://ergomedcro.com/prioritizing-patient-voices/ 2025-06-26T03:43:39+00:00 https://ergomedcro.com/creating-operational-efficiency-and-competitive-edge/ 2025-07-08T00:03:49+00:00 https://ergomedcro.com/understanding-trauma-and-support-in-clinical-trials/ 2025-07-09T13:39:09+00:00 https://ergomedcro.com/ergomeds-solutions-to-the-challenges-of-oncology-trials/ 2025-07-14T03:18:22+00:00 https://ergomedcro.com/wp-content/uploads/2024/08/Cel-Sci-case-study-website-header.png https://ergomedcro.com/advancing-immunotherapy-in-head-and-neck-cancer-the-it-matters-study/ 2025-07-14T05:27:05+00:00 https://ergomedcro.com/navigating-the-7-biggest-challenges-in-rare-disease-clinical-trials-with-a-rare-disease-cro/ 2025-07-14T06:48:39+00:00 https://ergomedcro.com/exploring-the-challenges-of-designing-and-executing-first-in-human-oncology-trials/ 2025-07-23T15:42:02+00:00 https://ergomedcro.com/wp-content/uploads/2024/09/OCT24-Patient-Advocacy-webinar-registration-page.jpg https://ergomedcro.com/how-pharmaceutical-companies-can-effectively-engage-with-patient-advocacy-organizations-paos/ 2025-07-28T05:05:54+00:00 https://ergomedcro.com/wp-content/uploads/2024/09/OCT24-Patient-Advocacy-webinar-registration-page.jpg https://ergomedcro.com/supporting-the-entire-patient-network/ 2025-07-28T05:19:35+00:00 https://ergomedcro.com/blog-the-path-forward-in-oncology-trials/ 2025-07-28T11:43:33+00:00 https://ergomedcro.com/blog-the-strategic-role-of-biostatistics-in-clinical-trials/ 2025-07-28T11:47:27+00:00 https://ergomedcro.com/how-high-performing-trials-operationalize-health-equity-early/ 2025-08-08T02:08:48+00:00 https://ergomedcro.com/why-inclusive-clinical-trials-win-on-science-speed-and-spend/ 2025-08-08T02:09:22+00:00 https://ergomedcro.com/choosing-the-right-cro-for-rare-disease-trials/ 2025-08-27T11:12:37+00:00 https://ergomedcro.com/designing-successful-cell-and-gene-therapy-trials/ 2025-09-01T01:35:44+00:00 https://ergomedcro.com/strategic-cmc-considerations-for-pre-ind-meetings/ 2025-09-01T02:03:05+00:00 https://ergomedcro.com/delivering-successful-cell-and-gene-therapy-trials/ 2025-10-05T14:36:34+00:00 https://ergomedcro.com/optimizing-the-target-product-profile-tpp-for-smarter-cmc-and-clinical-planning-in-cgt/ 2025-10-09T01:25:24+00:00 https://ergomedcro.com/the-importance-of-proactive-site-relationships-in-accelerating-your-study-start-up/ 2025-10-09T01:34:33+00:00 https://ergomedcro.com/regulatory-dashboard-act-now-ema-urges-timely-submission-for-ctr-transition/ 2025-10-09T02:21:59+00:00 https://ergomedcro.com/wp-content/uploads/2024/08/RD-whitepaper-CTR-transition.png https://ergomedcro.com/regulatory-dashboard-regulatory-frameworks-for-advanced-therapies-in-europe-and-the-united-states/ 2025-10-09T02:28:00+00:00 https://ergomedcro.com/wp-content/uploads/2024/08/cell_and_gene_therapy_1920x960px.jpg https://ergomedcro.com/mastering-21-cfr-part-312-navigating-the-investigational-new-drug-application-process-and-beyond-2/ 2025-10-09T02:29:42+00:00 https://ergomedcro.com/wp-content/uploads/2024/09/OCT24-Patient-Advocacy-webinar-registration-page.jpg https://ergomedcro.com/webinar-navigating-the-european-gmo-framework/ 2025-10-09T02:30:12+00:00 https://ergomedcro.com/navigating-gmo-landscape-following-the-eu-clinical-trial-regulation-536-2014-implementation-2/ 2025-10-09T02:30:41+00:00 https://ergomedcro.com/radiopharmaceutical-oncology-expertise/ 2025-10-09T14:41:08+00:00 https://ergomedcro.com/insights-whitepaper-gene-therapies-for-rare-diseases/ 2025-10-10T12:10:48+00:00 https://ergomedcro.com/rethinking-early-phase-oncology-study-design/ 2025-10-15T10:15:22+00:00 https://ergomedcro.com/site-management-support-to-investigational-sites-in-rare-disease-clinical-trials/ 2025-10-21T09:51:55+00:00 https://ergomedcro.com/5-key-questions-on-adaptive-clinical-trial-designs/ 2025-10-28T10:20:54+00:00 https://ergomedcro.com/adaptive-designs-in-early-phase-oncology-trials-a-smarter-path-to-dose-optimization/ 2025-10-28T10:21:50+00:00 https://ergomedcro.com/transforming-clinical-trials-through-intelligent-site-support/ 2025-11-12T10:13:18+00:00 https://ergomedcro.com/building-a-strategic-partnership-with-your-cro/ 2025-11-12T10:29:57+00:00 https://ergomedcro.com/ergomed-cro-expands-global-presence-with-strategic-growth-in-latin-america/ 2025-11-19T10:24:26+00:00 https://ergomedcro.com/wp-content/uploads/2025/11/ERGOMED-CRO-Expands-Global-Presence-with-Strategic-Growth-in-Latin-America-scaled.png https://ergomedcro.com/the-critical-role-of-early-medical-assessment-in-clinical-trials/ 2025-12-08T01:55:15+00:00 https://ergomedcro.com/the-power-of-medical-insight-in-early-phase-clinical-development/ 2025-12-08T01:59:35+00:00 https://ergomedcro.com/insights-guide-sponsor-checklist-for-expanded-access/ 2025-12-25T16:34:07+00:00 https://ergomedcro.com/insights-guide-reimagining-medical-monitoring-in-clinical-research/ 2026-01-10T01:40:35+00:00 https://ergomedcro.com/harnessing-ai-for-pre-award-landscape-analysis-and-site-selection/ 2026-01-15T15:14:36+00:00 https://ergomedcro.com/five-hidden-failure-points-in-fih-oncology-trials-sponsors-rarely-anticipate/ 2026-02-01T19:06:30+00:00 https://ergomedcro.com/vendor-management-as-a-strategic-enabler-of-clinical-trial-execution/ 2026-02-17T01:34:33+00:00 https://ergomedcro.com/site-selection-solutions-using-patient-insights-for-rare-disease-trials/ 2026-02-25T11:55:50+00:00 https://ergomedcro.com/scaling-ai-in-drug-development-by-turning-fda-ema-ai-principles-into-governance-advantage/ 2026-03-04T09:58:41+00:00 https://ergomedcro.com/rare-disease-site-selection-a-patient-centered-approach-to-feasibility-and-enrollment-success/ 2026-03-19T11:58:37+00:00 https://ergomedcro.com/improving-rare-disease-clinical-trial-enrollment-through-patient-centered-site-selection/ 2026-03-19T16:57:42+00:00 https://ergomedcro.com/which-fih-decisions-are-hardest-to-reverse-later/ 2026-03-19T17:18:26+00:00 https://ergomedcro.com/insights-guide-fdas-2025-patient-focused-drug-development-guidance/ 2026-03-19T17:32:10+00:00 https://ergomedcro.com/insights-guide-expanded-access-to-investigational-drugs/ 2026-03-19T17:43:05+00:00 https://ergomedcro.com/how-to-implement-adaptive-dose-escalation-designs-in-oncology-trials/ 2026-03-19T17:54:44+00:00 https://ergomedcro.com/leading-rare-disease-research/ 2026-03-19T19:10:54+00:00 https://ergomedcro.com/advancing-oncology-research/ 2026-03-19T19:21:43+00:00 https://ergomedcro.com/case-study-idea-to-market/ 2026-03-24T01:23:56+00:00 https://ergomedcro.com/case-study-she-said-yes/ 2026-03-24T01:26:16+00:00 https://ergomedcro.com/the-developakure-project-2/ 2026-03-24T01:29:44+00:00 https://ergomedcro.com/cross-border-enrollment/ 2026-03-24T01:35:41+00:00 https://ergomedcro.com/ergomed-group-announces-board-chair-transition/ 2026-04-07T23:05:22+00:00 https://ergomedcro.com/wp-content/uploads/2026/04/ERGOMED-Group_Teams-Background_v5-scaled.png https://ergomedcro.com/delivering-a-phase-iii-allergy-study-within-a-single-seasonal-window/ 2026-04-15T12:18:43+00:00 https://ergomedcro.com/ergomed-clinical-research-named-finalist-in-fierce-outsourcing-awards-2026-for-clinical-trial-management/ 2026-04-15T12:20:50+00:00 https://ergomedcro.com/wp-content/uploads/2026/04/Fierce-Outsourcing-Awards-2026-2.png https://ergomedcro.com/insights-case-study-in-the-face-of-adversity/ 2026-04-26T23:18:19+00:00 https://ergomedcro.com/case-study-rare-solutions/ 2026-04-26T23:29:44+00:00 https://ergomedcro.com/regulatory-dashboard-regulatory-aspects-of-rescuing-a-study/ 2026-04-27T00:02:06+00:00 https://ergomedcro.com/whitepaper-accelerating-rare-disease-drug-development-a-strategic-framework-to-guide-planning-for-success/ 2026-04-27T00:03:10+00:00 https://ergomedcro.com/wp-content/uploads/2024/08/White_Paper_blu.hero_.png https://ergomedcro.com/whitepaper-decentralization-and-innovation-approaches-to-advance-rare-disease-drug-development/ 2026-04-27T00:04:21+00:00 https://ergomedcro.com/wp-content/uploads/2024/08/White_Paper_blu.hero_.png https://ergomedcro.com/regulatory-dashboard-decentralized-clinical-trials-in-the-eu/ 2026-04-27T00:07:29+00:00 https://ergomedcro.com/wp-content/uploads/2024/08/carousel_virtual_1600x800px.jpg https://ergomedcro.com/whitepaper-improving-access-to-cancer-immunotherapy/ 2026-04-27T00:31:04+00:00 https://ergomedcro.com/wp-content/uploads/2024/08/White_Paper_blu.hero_.png https://ergomedcro.com/maximizing-the-potential-of-site-centric-services-discover-ergomeds-distinctive-site-manager-role/ 2026-04-27T00:44:46+00:00 https://ergomedcro.com/wp-content/uploads/2024/08/Webinar-resource-header-image-2023.png https://ergomedcro.com/white-paper-optimizing-backfilling-strategies-for-phase-i-oncology-studies/ 2026-04-27T00:47:19+00:00 https://ergomedcro.com/regulatory-dashboard-gmo-regulatory-considerations-for-advanced-therapies-in-europe/ 2026-04-27T00:51:01+00:00 https://ergomedcro.com/wp-content/uploads/2024/08/GMO-title-image_regulatory-dashboard.png https://ergomedcro.com/writing-an-ind-module-3-for-cell-and-gene-therapy-products-considerations-and-challenges/ 2026-04-27T00:53:26+00:00 https://ergomedcro.com/wp-content/uploads/2024/08/Module-3-Gene-Therapy-whitepaper-1.png https://ergomedcro.com/ergomeds-approach-to-complex-clinical-trial-management/ 2026-04-27T00:58:27+00:00 https://ergomedcro.com/wp-content/uploads/2024/08/Alentis-case-study-website-header-1.png https://ergomedcro.com/choosing-the-right-cro-for-your-rare-disease-program-key-considerations-and-best-practices/ 2026-04-27T01:01:03+00:00 https://ergomedcro.com/a-journey-of-overcoming-obstacles-and-maximizing-patient-enrollment/ 2026-04-27T01:03:58+00:00 https://ergomedcro.com/wp-content/uploads/2024/08/IMGN-420-Case-Study.png https://ergomedcro.com/pioneering-success-in-rare-disease-clinical-trials/ 2026-04-27T01:09:25+00:00 https://ergomedcro.com/regulatory-dashboard-navigating-rare-diseases-considerations-for-the-development-of-drugs-and-biological-products-guidance-for-industry/ 2026-04-27T01:40:49+00:00 https://ergomedcro.com/wp-content/uploads/2024/08/RD-whitepaper.png https://ergomedcro.com/whitepaper-patient-reported-outcome-in-oncology-clinical-trials/ 2026-04-27T03:01:08+00:00 https://ergomedcro.com/wp-content/uploads/2024/08/White_Paper_blu.hero_.png https://ergomedcro.com/anti-body-conjugates-a-new-step-forward-for-breast-cancer-patients/ 2026-04-27T03:06:10+00:00 https://ergomedcro.com/wp-content/uploads/2024/08/Antibody-Image.png https://ergomedcro.com/regulatory-dashboard-navigating-fdas-guidance-on-potency-assurance-for-cellular-and-gene-therapy-products/ 2026-04-27T03:12:07+00:00 https://ergomedcro.com/wp-content/uploads/2024/08/RD-FDA-potency-guidance.png https://ergomedcro.com/accelerating-clinical-trials-with-strategic-excellence/ 2026-04-27T03:20:07+00:00 https://ergomedcro.com/international-clinical-trials-day-2026-keeping-patients-at-the-center-of-clinical-research/ 2026-05-20T12:40:21+00:00 https://ergomedcro.com/uk-mhra-clinical-trial-regulations-are-now-in-effect-what-sponsors-should-prepare-for/ 2026-05-22T13:02:50+00:00 https://ergomedcro.com/head-and-neck-oncology-expertise/ 2026-06-03T10:28:36+00:00 https://ergomedcro.com/pre-ind-cmc-checklist-for-regulatory-success/ 2026-06-03T10:30:29+00:00 https://ergomedcro.com/best-biostatistics-practices-to-drive-clinical-trial-success/ 2026-06-03T10:31:35+00:00 https://ergomedcro.com/guide-how-to-reduce-barriers-and-improve-trust-in-complex-clinical-trials/ 2026-06-03T10:32:19+00:00 https://ergomedcro.com/guide-advancing-neuromuscular-research/ 2026-06-03T10:33:43+00:00 https://ergomedcro.com/insights-guide-transforming-first-in-human-oncology-trials/ 2026-06-03T10:36:48+00:00 https://ergomedcro.com/insights-casestudy-a-sponsors-path-to-meaningful-pao-engagement/ 2026-06-03T10:44:49+00:00 https://ergomedcro.com/post-market-safety-risk-management-in-duchenne-muscular-dystrophy-dmd/ 2026-06-03T10:47:30+00:00 https://ergomedcro.com/market-approval-for-a-novel-non-hodgkin-lymphoma-nhl-therapy/ 2026-06-03T10:49:15+00:00 https://ergomedcro.com/early-stage-development-in-rare-pediatric-oncology/ 2026-06-03T10:50:58+00:00 https://ergomedcro.com/empowering-success-across-the-drug-development-journey/ 2026-06-03T10:53:46+00:00 https://ergomedcro.com/strategic-pre-ind-consulting-for-gene-therapy-in-rare-leukemia/ 2026-06-03T10:55:37+00:00 https://ergomedcro.com/insights-casestudy-accelerating-early-phase-oncology-study-development/ 2026-06-03T10:59:42+00:00 https://ergomedcro.com/integrating-clinical-operations-and-pharmacovigilance-for-safer-trials/ 2026-06-17T22:12:40+00:00 https://ergomedcro.com/ergomed-delivers-one-of-the-worlds-largest-head-neck-cancer-trials-now-published-in-oral-oncology/ 2026-08-20T11:57:24+00:00 https://ergomedcro.com/wp-content/uploads/2026/04/Ergomed_Group_futuristic_medical_visualization_of_head_and_ne_f893cf32-a8ac-44cd-9651-6e51d7e0ecdc_2.png